Quantification of serum IgG subclasses by use of subclass-specific tryptic peptides and liquid chromatography - Tandem mass spectrometry

Clinical Chemistry

Volumn 60, Issue 8, 2014, Pages 1080-1088

  Ladwig, Paula M ^a   Barnidge, David R ^a   Snyder, Melissa R ^a   Katzmann, Jerry A ^a   Murray, David L ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; IMMUNOGLOBULIN BLOOD LEVEL; LIQUID CHROMATOGRAPHY; TANDEM MASS SPECTROMETRY;

CHROMATOGRAPHY, LIQUID; HUMANS; IMMUNOGLOBULIN G; PEPTIDE MAPPING; REFERENCE STANDARDS; TANDEM MASS SPECTROMETRY; TRYPSIN;

EID: 84905242220     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2014.222208     Document Type: Article

References (23)

1. Kutukculer N, Karaca NE, Demircioglu O, Aksu G. Increases in serum immunoglobulins to agerelated normal levels in children with IgA and/or IgG subclass deficiency. Pediatr Allergy Immunol 2007;18:167-73. (Pubitemid 46333721)
2. Skoug JW, Pardue HL. Effects of reaction variables on nephelometric and turbidimetric responses for the immunochemical reaction of immunoglobulin G. Clin Chem 1998;34:300-8.
3. Vlug A, Nieuwenhuys EJ, van Eijk RV, Geertzen HG, van Houte AJ. Nephelometric measurements of human IgG subclasses and their reference ranges. Ann Biol Clin (Paris) 1994;52:561-7. (Pubitemid 24338810)
4. Pressac M, Allouche F, Circaud R, Aymard P. Evaluation of human IgG subclass assays on Beckman array. Ann Clin Biochem 1995;32(Pt 3):281-8.
5. Rappaport I. The antibody-antigen reaction; an hypothesis to account for the presence of uncombined antigenic sites in the presence of excess antibody. J Immunol 1957;78:246-55.
6. Sternberg JC. A rate nephelometer for measuring specific proteins by immunoprecipitin reactions. Clin Chem 1977;23:1456-64. (Pubitemid 8163264)
7. Wei TQ, Kramer S, Chu VP, et al. An improved automated immunoassay for C-reactive protein on the Dimension clinical chemistry system. J Autom Methods Manag Chem 2000;22:125-31.
8. Montagne P, Laroche P, Cuilliere ML, Varcin P, Pau B, Duheille J. Microparticle-enhanced nephelometric immunoassay for human C-reactive protein. J Clin Lab Anal 1992;6:24-9.
9. Barnidge DR, Goodmanson MK, Klee GG, Muddiman DC. Absolute quantification of the model biomarker prostate-specific antigen in serum by LC-MS/MS using protein cleavage and isotope dilution mass spectrometry. J Proteome Res 2004;3:644-52. (Pubitemid 39207371)
10. Kumar V, Barnidge DR, Chen LS, Twentyman JM, Cradic KW, Grebe SK, Singh RJ. Quantification of serum 1-84 parathyroid hormone in patients with hyperparathyroidism by immunocapture in situ digestion liquid chromatography-tandem mass spectrometry. Clin Chem 2010;56:306-13.
11. Seegmiller JC, Barnidge DR, Burns BE, Larson TS, Lieske JC, Kumar R. Quantification of urinary albumin by using protein cleavage and LC-MS/MS. Clin Chem 2009;55:1100-7.
12. Anderson L, Hunter CL. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol Cell Proteomics 2006;5:573-88.
13. Chen Y, Snyder MR, Zhu Y, Tostrud LJ, Benson LM, Katzmann JA, Bergen HR. Simultaneous phenotyping and quantification of α-1-antitrypsin by liquid chromatography-tandem mass spectrometry. Clin Chem 2011;57:1161-8.
14. Whiteaker JR, Zhao L, Anderson L, Paulovich AG. An automated and multiplexed method for high throughput peptide immunoaffinity enrichment and multiple reaction monitoring mass spectrometry-based quantification of protein biomarkers. Mol Cell Proteomics 2010;9:184-96.
15. Hoofnagle AN, Becker JO, Oda MN, Cavigiolio G, Mayer P, Vaisar T. Multiple-reaction monitoring mass spectrometric assays can accurately measure the relative protein abundance in complex mixtures. Clin Chem 2012;58:777-81.
16. Hong Q, Lebrilla CB, Miyamoto S, Ruhaak LR. Absolute quantitation of immunoglobulin G and its glycoforms using multiple reaction monitoring. Anal Chem 2013;85:8585-93.
17. Annesley TM. Ion suppression in mass spectrometry. Clin Chem 2003;49:1041-4. (Pubitemid 36751088)
18. Stone JH, Khosroshahi A, Deshpande V, Chan JK, Heathcote JG, Aalberse R, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum 2012;64:3061-7.
19. Stone JH. IgG4-related disease: nomenclature, clinical features, and treatment. Semin Diagn Pathol 2012;29:177-90.
20. Ryu JH, Horie R, Sekiguchi H, Peikert T, Yi ES. Spectrum of disorders associated with elevated serum IgG4 levels encountered in clinical practice. Int J Rheumatol 2012;2012:232960.
21. Bjornsson E, Chari S, Silveira M, Gossard A, Takahashi N, Smyrk T, Lindor K. Primary sclerosing cholangitis associated with elevated immunoglobulin G4: clinical characteristics and response to therapy. Am J Ther 2011;18:198-205.
22. Oseini AM, Chaiteerakij R, Shire AM, Ghazale A, Kaiya J, Moser CD, et al. Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma. Hepatology 2011;54:940-8.
23. Khosroshahi A, Cheryk L, Carruthers MN, Edwards JA, Block DB, Stone JH. Brief report: spuriously low serum IgG4 concentrations caused by the prozone phenomenon in patients with IgG4-related disease. Arthritis Rheumatol 2014;66:213-7.